시장보고서
상품코드
1290572

세계의 이상헤모글로빈증 시장 : 검사 유형별, 적응증별, 최종 사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)

Hemoglobinopathy Market, by Test Type, by Indication, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이상헤모글로빈증은 헤모글로빈 분자의 생산과 구조에 이상이 있는 유전성 질환군입니다. 이상헤모글로빈증은 주로 적혈구에 영향을 미치는 유전성 혈액 질환 및 질병 그룹을 지칭하는 의학 용어입니다. 겸상적혈구증(SCD)은 비정상적인 헤모글로빈이 적혈구를 손상시키고 변형시켜 발생하는 혈액질환 중 하나입니다. 헤모글로빈 유전자의 돌연변이로 인한 구조적 이상헤모글로빈증과 정상 헤모글로빈 분자가 변형되어 발생하는 지중해빈혈증으로 크게 나뉩니다. 주요 구조형 헤모글로빈 변이체는 HbS, HbE, HbC가 있습니다. 지중해 빈혈의 주요 유형은 α- 지중해 빈혈과 β- 지중해 빈혈입니다. 헤모글로빈 단백질의 이상을 유발하는 일부 질병은 헤모글로빈 생산에도 영향을 미치기 때문에 두 질병이 겹칠 수 있습니다.

일부 헤모글로빈 이상은 병리학적 증상이나 빈혈을 일으키지 않기 때문에 이상헤모글로빈증으로 분류되지 않는 경우가 많습니다. 흔한 증상으로는 심한 통증, 숨가쁨, 비장 비대, 소아 성장 장애 등이 있습니다. 이상헤모글로빈증은 적혈구 내 헤모글로빈의 이상으로 인해 발생하는 질환군입니다.

시장 역학

제품 포트폴리오를 확대하기 위해 시장의 주요 업체들이 파트너십과 같은 유기적 성장 전략을 채택하는 경우가 증가하고 있으며, 이는 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2022년 6월 미국 임상 단계의 유전자 편집 기업 프리시전 바이오사이언스(Precision BioSciences)와 제약회사 노바티스(Novartis AG)는 혈액 질환에 대한 새로운 유전자 치료제를 개발하기 위해 파트너십을 체결했다고 발표했습니다.

본 조사의 주요 특징

  • 이 보고서는 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR)을 제공하는 세계 비정상적 헤모글로빈증 시장을 상세하게 분석합니다.
  • 다양한 부문의 잠재적 수익 기회를 파악하고 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역 전망 및 주요 기업이 채택한 경쟁 전략에 대한 중요한 고려 사항을 제공합니다.
  • 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등 다음 매개 변수를 기반으로 세계 비정상적 헤모글로빈증 시장의 주요 기업 프로파일을 제공합니다.
  • 이 조사에서 다룬 주요 기업은 Anamol Laboratories Pvt. Ltd., Bio-Rad Laboratories, Inc. Nanjing Poclight Biotechnology Co., Ltd, Abbott, Danaher, ReachBio LLC, Shenzhen Mindray Bio-Medical Electronics Co. ., NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, CRISPR Therapeutics. 등입니다.
  • 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사 결정을 내릴 수 있습니다.
  • 세계 이상헤모글로빈증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자는 세계 헤모글로비노병증 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 영향 분석
  • 주요 하이라이트
  • 제품 발매
  • 기술적 진보
  • PEST 분석
  • 법규제 시나리오
  • 인수합병(M&A)

제4장 세계의 이상헤모글로빈증 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • 경제적 영향
  • COVID-19 역학에 대해
  • 수요 및 공급에 대한 영향

제5장 세계의 이상헤모글로빈증 시장, 검사 유형별, 2017년-2030년

  • 루틴 적혈구(RBC) 카운트
  • 유전자 검사
  • 고속 액체 크로마토그래피를 이용한 헤모글로빈 검사
  • 헤모글로빈 등전 포커싱(Hb IEF)
  • 헤모글로빈 전기영동법(Hb ELP)
  • 헤모글로빈 용해도 시험

제6장 세계의 이상헤모글로빈증 시장, 적응증별, 2017년-2030년

  • 겸상 적혈구증
  • 베타 지중해빈혈
  • 알파 지중해빈혈

제7장 세계의 이상헤모글로빈증 시장, 최종사용자별, 2017년-2030년

  • 병원
  • 진단실험실
  • 진료소

제8장 세계의 이상헤모글로빈증 시장 : 지역별, 2017년-2030년

  • 북미
  • 미국
  • 캐나다
  • 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
  • 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
  • 중동 지역
  • GCC
  • 이스라엘
  • 기타 중동
  • 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카공화국

제9장 경쟁 구도

  • Anamol Laboratories Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Zentech
  • Sebia
  • Sysmex Europe SE
  • Nanjing Poclight Biotechnology Co., Ltd
  • Abbott
  • Danaher
  • ReachBio LLC
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Nexcelom Bioscience LLC.
  • NIHON KOHDEN CORPORATION
  • Siemens Healthcare GmbH
  • CRISPR Therapeutics

제10장 섹션

  • 조사 방법에 대해
  • 출판사에 대해
lsh 23.06.30

Hemoglobinopathy are a group of disorders that are inherited, in which there is abnormal production or structure of the hemoglobin molecule. Hemoglobinopathy is the medical term for a group of inherited blood disorders and diseases that primarily affect red blood cells. Sickle cell disease (SCD) is one such blood disorder caused by the abnormal hemoglobin that damages and deforms red blood cells. There are two main groups, which are abnormal structural hemoglobin variants caused by mutations in the hemoglobin genes, and the thalassemias, which are caused by an alteration in normal hemoglobin molecules. The main structural hemoglobin variants are HbS, HbE and HbC. The main types of thalassemia are alpha-thalassemia and beta thalassemia. The two conditions may overlap because some conditions, which cause abnormalities in hemoglobin proteins also affect their production.

Some hemoglobin variants do not cause pathology or anemia, and thus are often not classed as hemoglobinopathies. Common symptoms of the condition include, severe pain, shortness of breath, enlarged spleen, and growth problems in children. It can be any group of disorders caused by the presence of variant hemoglobin in the red blood cells.

Market Dynamics

Increasing adoption of organic growth strategies, such as partnerships by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2022, Precision BioSciences, a publicly traded American clinical stage gene editing company, and Novartis AG, a pharmaceutical corporation, announced that they have entered into a partnership to develop new gene therapy for blood disorders.

Key features of the study:

  • This report provides in-depth analysis of the global hemoglobinopathy market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hemoglobinopathy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Anamol Laboratories Pvt. Ltd., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Zentech, Sebia, Sysmex Europe SE, Nanjing Poclight Biotechnology Co., Ltd, Abbott, Danaher, ReachBio LLC, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nexcelom Bioscience LLC., NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, CRISPR Therapeutics.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global hemoglobinopathy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemoglobinopathy market

Detailed Segmentation:

  • Global Hemoglobinopathy Market, By Test Type:
    • Routine Red Blood Cell (RBC) count
    • Genetic Testing
    • Hemoglobin by high performance liquid chromatography
    • Hemoglobin isoelectric focusing ( Hb IEF)
    • Hemoglobin electrophoresis (Hb ELP)
    • Hemoglobin solubility test
  • Global Hemoglobinopathy Market, By Indication:
    • Sickle Cell Disease
    • Beta Thalassemia
    • Alpha Thalassemia
  • Global Hemoglobinopathy Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Clinics
  • Global Hemoglobinopathy Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Anamol Laboratories Pvt. Ltd.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer Inc.
    • Zentech
    • Sebia
    • Sysmex Europe SE
    • Nanjing Poclight Biotechnology Co., Ltd
    • Abbott
    • Danaher
    • ReachBio LLC
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Nexcelom Bioscience LLC.
    • NIHON KOHDEN CORPORATION
    • Siemens Healthcare GmbH.
    • CRISPR Therapeutics

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Test Type
    • Market Snapshot, By Indication
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launch
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Hemoglobinopathy Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Hemoglobinopathy Market, By Test Type, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Routine Red Blood Cell (RBC) count
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Genetic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hemoglobin by high performance liquid chromatography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hemoglobin isoelectric focusing ( Hb IEF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hemoglobin electrophoresis (Hb ELP)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hemoglobin solubility test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Hemoglobinopathy Market, By Indication, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Sickle Cell Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Beta Thalassemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Alpha Thalassemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Hemoglobinopathy Market, By End User, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Hemoglobinopathy Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Anamol Laboratories Pvt. Ltd.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zentech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sebia
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sysmex Europe SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nanjing Poclight Biotechnology Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ReachBio LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nexcelom Bioscience LLC.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NIHON KOHDEN CORPORATION
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthcare GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CRISPR Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제